To further understand the molecular mechanism of irisin as a candidate for the prevention and treatment of obesity and related metabolic disorders, we examined whether GST-irisin could promote its autocrine function in mature 3T3-L1 adipocytes. The gene discussed is FNDC5; the disease is metabolic disease.